Sangmi Lee
Papers
2
Total Citations
164
H-Index
2
About
Dr. Sangmi Lee is a leading urologic surgeon and researcher whose work has fundamentally advanced the surgical management of prostate cancer. Her primary research focuses on comparative effectiveness in radical prostatectomy, particularly the transition from traditional open retropubic approaches to robot-assisted techniques. Dr. Lee’s landmark 2011 study, which has garnered 146 citations, established critical benchmarks for functional outcomes following robot-assisted versus retropubic radical prostatectomy, providing surgeons and patients with evidence-based guidance for treatment selection. She further extended this work by evaluating oncologic outcomes in high-risk prostate cancer patients, demonstrating that robot-assisted radical prostatectomy achieves comparable surgical margin status and biochemical recurrence-free survival rates to open surgery, even in this challenging population. Her research has been instrumental in validating the oncologic safety and functional benefits of minimally invasive robotic approaches, helping to shape modern surgical standards. Dr. Lee’s contributions continue to influence clinical practice, offering clarity on the optimal surgical strategy for men facing prostate cancer treatment decisions.
Research Focus
Key Achievements
Top Papers
- 1
- 2